Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA

Clinical trial NCT05461664 · RECRUITING

Trial details

NCT number: NCT05461664
Sponsor: Xinhua Zhang, MD
Status: RECRUITING
Study type: OBSERVATIONAL

Gastrointestinal Stromal Tumors Unresectable Solid Tumor Recurrent Metastatic Malignant Neoplasm

Start date: 2022-07-10
Primary completion: 2025-12-31
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.